Day: December 10, 2024

OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219

Written by Customer Service on December 10, 2024. Posted in Public Companies.

— OKI-219 is well-tolerated across all doses, and no dose interruptions, delays, reductions, or discontinuations were reported — Initial patient data show exposures of OKI-219 exceeding levels associated with robust antitumor activity in preclinical models — Data support the initiation of Part 1b of PIKture-01 evaluating OKI-219 in combination with fulvestrant; first patients dosed, and initial data are expected in 2H-2025 — Management to host conference call today, December 10, 2024 at 7:00 a.m. CT BOULDER, Colo., Dec. 10, 2024 (GLOBE NEWSWIRE) — OnKure Therapeutics, Inc. (NASDAQ: OKUR), a clinical-stage biopharmaceutical company focused on the development of novel precision medicines in oncology, today announced encouraging safety, tolerability, and pharmacokinetic data from the ongoing first-in-human...

NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROADWAY Clinical Trial Evaluating Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia

Written by Customer Service on December 10, 2024. Posted in Public Companies.

— Achieved primary endpoint of LS mean reduction vs placebo in LDL-C on top of maximally tolerated lipid modifying therapies at day 84 with statistically significant reduction (p

Troilus Announces Positive Environmental Study Results, Confirms Low Acidity and Natural Neutralizing Properties of Ore Zones

Written by Customer Service on December 10, 2024. Posted in Public Companies.

MONTREAL, Dec. 10, 2024 (GLOBE NEWSWIRE) — Troilus Gold Corp. (“Troilus” or the “Company”) (TSX: TLG; OTCQX: CHXMF; FSE: CM5R) is pleased to announce the results of a targeted research program at its copper-gold Troilus Project in north-central Quebec. The studies, a collaboration between Coalia, National Research Council of Canada, Lamont and Minesite Drainage Assessment Group (MDAG), reveal that the main ore zones at Troilus (J4, 87, and Southwest) show minimal potential for Acid Rock Drainage (ARD)—a process by which certain minerals, when exposed to air and water, can generate acidic water runoff. This assessment supports Troilus’s commitment to environmentally responsible development and strengthens the project’s profile as a sustainable operation. Key Findings:Low Risk of Acidic Drainage: Analysis of over 158,000 rock samples...

G-III Apparel Group, Ltd. Reports Third Quarter Fiscal 2025 Results Above Guidance; Updates Fiscal 2025 Outlook

Written by Customer Service on December 10, 2024. Posted in Earnings Releases And Operating Results.

Third Quarter GAAP and Non-GAAP Net Income Per Diluted Share Exceed Guidance Net Sales of $1.09 Billion for the Third Quarter Compared to $1.07 Billion Last Year Net Income Per Diluted Share of $2.55 for the Third Quarter Compared to $2.74 Last Year Non-GAAP Net Income Per Diluted Share of $2.59 for the Third Quarter Compared to $2.78 Last Year Raises GAAP and Non-GAAP Net Income Per Diluted Share Guidance for Fiscal 2025NEW YORK, Dec. 10, 2024 (GLOBE NEWSWIRE) — G-III Apparel Group, Ltd. (NasdaqGS: GIII) today reported results for the third quarter of fiscal 2025 ended October 31, 2024. Morris Goldfarb, G-III’s Chairman and Chief Executive Officer, said, “I am very pleased with our strong third quarter results, with earnings per diluted share exceeding our expectations, driven by over 30% organic growth of our key owned brands...

MoneyHero Group Reports Third Quarter 2024 Results

Written by Customer Service on December 10, 2024. Posted in Earnings Releases And Operating Results.

Third quarter revenue of US$20.9 million, up 6% Year-Over-Year SINGAPORE, Dec. 10, 2024 (GLOBE NEWSWIRE) — MoneyHero Limited (Nasdaq: MNY) (“MoneyHero” or the “Company”), a market leading personal finance and digital insurance aggregation and comparison platform in Greater Southeast Asia, today announced financial results for the quarter ended September 30, 2024. Management Commentary: Rohith Murthy, Chief Executive Officer, stated: “I am pleased to report another solid quarter for MoneyHero Group as we continue executing on our priorities to drive efficiency and focus on high-margin products. Q3 marks the beginning of our deliberate shift to an ‘efficiency’ strategy, aimed at optimizing our cost base while building for long-term sustainable growth. “During the third quarter, we initiated a comprehensive reorganization and restructuring...

Better Choice Company Increases Capital Stock Distribution of Halo as Part of the SRx Health Transaction from an 8% to 17% Dividend

Written by Customer Service on December 10, 2024. Posted in Dividend Reports And Estimates.

TAMPA, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) — Better Choice Company (NYSE: BTTR) (“Better Choice” or “the Company”), a pet health and wellness company, today announced that as part of the acquisition of SRx Health Solutions Inc. (‘SRx Health’), a leading provider of innovative healthcare solutions, the capital stock distribution of Halo, Purely for Pets, Inc. has increased from an 8% to 17% dividend. The closing of the transaction is subject to customary closing conditions, including the receipt of required shareholder approvals from SRx Health and Better Choice. The transaction is expected to close during the first quarter of 2025. About Better Choice Company Inc. Better Choice Company Inc. is a rapidly growing pet health and wellness company committed to leading the industry shift toward pet products and services that help dogs...

Bayport Management Ltd announces the record date and exchange date for the exchange of its outstanding senior and subordinated social bonds.

Written by Customer Service on December 10, 2024. Posted in Public Companies.

Bayport Management Ltd announces the record date and exchange date for the exchange of its outstanding senior and subordinated social bondsAttachmentsBayport Management Limited – Press Release (Announcement CSD Record Date) – 10 Dec 2024_Bayport Management Limited – Press Release (Announcement CSD Record Date) – 10 Dec 2024_

Cardiff Oncology Prices Oversubscribed $40 Million Underwritten Registered Direct Offering

Written by Customer Service on December 10, 2024. Posted in Public Companies.

SAN DIEGO, Dec. 10, 2024 (GLOBE NEWSWIRE) — Cardiff Oncology, Inc. (Nasdaq: CRDF) (“Cardiff Oncology” or the “Company”), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced the pricing of an underwritten offering of 15,384,619 shares of its common stock at an offering price of $2.60 per share, before deducting underwriting discounts and commissions. All of the shares of common stock are being offered by the Company. The financing included participation from new mutual fund and healthcare dedicated investors, along with support from existing investors. The gross proceeds to the Company, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $40 million. The offering is expected to close on...

Vow ASA: Final results of the rights issue

Written by Customer Service on December 10, 2024. Posted in Public Companies.

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. Oslo, 10 December 2024: Reference is made to the stock exchange announcement published by Vow ASA (the “Company“) on 19 November 2024 regarding the approval by the extraordinary general meeting of the Company of a fully underwritten rights issue of 166,666,666 new shares in the Company (the “Offer Shares“), at a subscription price of NOK 1.50 per share...

CANADA CARBON ANNOUNCES PRIVATE PLACEMENT OF FLOW-THROUGH UNITS

Written by Customer Service on December 10, 2024. Posted in Public Companies.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES Toronto, ON, Canada, Dec. 10, 2024 (GLOBE NEWSWIRE) — Canada Carbon Inc. (the “Company“) (TSX-V : CCB) is pleased to announce a non-brokered private placement of up to 27,500,000 flow-through units (each, a “FT Unit”) at a price of $0.02 per FT Unit for aggregate gross proceeds of up to $550,000 (the “Offering”). Each FT Unit shall be comprised of one (1) flow-through share in the capital of the Company (each, a “FT Share”) and one (1) common share purchase warrant (each, a “Warrant”). Each whole Warrant shall entitle the holder thereof to acquire one (1) common share in the capital of the Company at a price of $0.07 per share for...

Day: December 10, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals